Ogenix markets and sells the EPIFLO line of medical devices used for treatment of various wounds as indicated by the FDA. Ogenix has received a 510K clearance by the FDA, a CE Mark for clearance into the European market, and is also cleared in Canada by Health Canada. EPIFLO has been used by doctors, hospitals, skilled nursing facilities, and long term care facilites for treatment of Bed Sores (Decubitus Ulcers) and by Podiatrists and Physicians for the treatment of chronic lower extremity wounds such as Diabetic Foot Ulcers and Venous Leg Ulcers (Venous Stasis). Contact us for recent information about other types of chronic wounds.
